wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36615056-E5697BCF-AAE3-47A5-87DC-3FB18B968BE6
Q36615056-E5697BCF-AAE3-47A5-87DC-3FB18B968BE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36615056-E5697BCF-AAE3-47A5-87DC-3FB18B968BE6
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
P2860
Q36615056-E5697BCF-AAE3-47A5-87DC-3FB18B968BE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36615056-E5697BCF-AAE3-47A5-87DC-3FB18B968BE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12fe5dbc189fe1a0eae61b1d67f8a6f293079eb0
P2860
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.